stephen michael korbet, md, facp - rush university medical... · 1979-1980 internship-...

Stephen Michael Korbet, MD, MACP, FASN

CURRICULUM VITAE

12/9/2016

DATE OF BIRTH: June 13,1953

PLACE OF BIRTH: Alton, Illinois

BUSINESS ADDRESS: 1426 W. Washington Blvd, Chicago, Illinois 60607

TELEPHONE: 312-850-8434 (work)

312-850-8431 (fax)

COLLEGE:

1971-1975 Millikin University, BA, Summa Cum Laude

MEDICAL SCHOOL:

1975-1979 Rush Medical College

TRAINING Internal Medicine/Nephrology:

1979-1980 Internship- Rush-Presbyterian-St. Lukes Medical Center (RPSLMC)

1980-1982 Residency-RPSLMC

1982-1984 Fellowship/Nephrology-RPSLMC

CERTIFICATION:

1980 National Board of Medical Examiners

1982 American Board of Internal Medicine (#85976)

1986 American Board of Internal Medicine/Nephrology (#85976)

1999 American Society of Hypertension Specialist in Clinical Hypertension (#0262)

HONORS / AWARDS:

1973 Alpha Epsilon Delta (Honorary Pre-Med Society)

1973 Sigma Zeta (Honorary Science Society)

1975 Phi Kappa Phi (Honorary Scholastic Society)

1979 Alpha Omega Alpha

1982 RPSLMC-Department of Internal Medicine Award for Outstanding Resident

1985 Chicago Society of Internal Medicine- Robert M. Kark Prize for Research

1991 RPSLMC-Department of Internal Medicine Teaching and Service Award

1994-1995 Best Doctors in America (Woodward/White, Inc)

1995 International Who's Who in Medicine (Int Biographical Ctr, Cambridge, England)

1996-1997 Best Doctors in America: Midwest Region (Woodward/White, Inc)

1996 Who's ,Who in Medicine and Healthcare (Marquis Who's Who)

1997 Chicago's Top Doctors (Chicago Magazine, January 1997)

1998 Best Doctors in America,4th Edition (Woodward/White, Inc)

1999 RPSLMC-Department of Internal Medicine Teaching and Service Award

2001 Top Doctors: Chicago Metro Area (Castle Connolly)

2001-2002 Best Doctors for 2001-2002 (Best Doctors, Inc)


2003 Who's ,Who in Medicine and Healthcare (Marquis Who's Who)




2007-2008 Best Doctors in America for 2007-2008 (Best Doctors, Inc)



Page - 2

2011 East Alton Wood River High School Hall of Fame Inductee

2013 Best Doctors in America for 2013 (Best Doctors, Inc)

2013 Top Doctors for 10 years (Castle Connolly)

2013 Top Doctors (Castle Connolly)

2014 Best Doctors in America for 2014 (Best Doctors, Inc)



STAFF POSITIONS:

1983-1984 Adjunct Attending, Department of Internal Medicine, RPSLMC

1984-1988 Assistant Attending, Section of Nephrology, Department of Internal Medicine, RPSLMC

1988-2007 Associate Attending, Section of Nephrology, Department of Internal Medicine, RUMC

1999-2007 Associate Attending, Section of Nephrology, Department of Pediatrics, RPSLMC

2007-present Senior Attending, Section of Nephrology, Department of Internal Medicine, RUMC

ACADEMIC APPOINTMENTS:

1979-1983 Assistant, Internal Medicine, Rush Medical College

1983-1984 Instructor, Internal Medicine, Rush Medical College

1984-1990 Assistant Professor, Internal Medicine, Rush Medical College

1990-1995 Associate Professor, Internal Medicine, Rush Medical College

1995-present Professor, Internal Medicine, Rush Medical College

1999-present Professor, Pediatrics, Rush Medical College

2000-present Professor, Pathology, Rush Medical College

2004-present The Lester and Muriel Anixter Professor of Nephrology

COMMITTEE MEMBERSHIPS:

1985-1987 Admissions Committee, Rush Medical College

1989-1995 Medical Advisory Board Members Executive Committee, NKF of Ill.

1989 Medical Staff Senate Representative, RPSLMC

1990-1994 Renal Network of Illinois

1991-1992 Renal Network of Illinois, Vice Chairman of the Medical Review Board

1993-1994 Renal Network of Illinois, Vice Chairman of the Board of Directors

1993-1994 Renal Network of Illinois, Chairman of the Medical Review Board

1994-1996 Crescent Counties Foundation for Medical Care, End Stage Renal Disease

Network 10, Governing Council

1996 National Kidney Foundation Fellowship Grant Review Committee

1996-1997 National Kidney Foundation Council on Glomerulonephritis

1996-1999 Committee on Committees, Rush Medical College

1998-2000 International Ad Hoc Committee on Ultrafiltration Management in

Peritoneal Dialysis [BAXTER]

1998-2006 International Society of Peritoneal Dialysis committee on Education and Standards

1998-2004 Kidney Dialysis Outcomes and Quality Initiatives (K/DOQI) Peritoneal Dialysis

Adequacy Work Group [National Kidney Foundation]

2000 Medical Staff Executive Committee Nominating Committees, RPSLMC

2002-2014 The Renal Network, Inc., Board of Trustees

2002-2010 The Renal Network, Inc., Strategic Planning Committee

2002-2006 Physician Accountability Committee (ASN/RPA), Associate Chair

2002-2007 Scientific Integrity & Conflict of Interest Committee, RPSLMC

2003 ASN/RPA Joint Coordinating Committee

2005-2008 ASN Postgraduate Education Commitee

Page - 3

2008-2011 Faculty Council, RUMC

2008-2014 Medical Advisory Committee, Dept of Med., RUMC

2012 RUMC Search Committee for Chairman of Urology

2013- RUMC Internal Medicine Peer Review Committee

2013-2015 Network Strategies Inc., Board of Trusties

2016- Faculty Council, RUMC

ADMINISTRATIVE APPOINTMENTS:

1984-1988 Medical Director, Dialysis Unit, RPSLMC

1988-Present Medical Director, Circle Medical Management Dialysis Facility

1992-2009 Associate Director, Section of Nephrology, RPSLMC

1998-2002 Councilor, Alpha Omega Alpha Honor Medical Society

1999-2000 Medical Director, Pediatric Dialysis Unit, RPSLMC

2009-present Division Chief, Nephrology

RESEARCH GRANTS/PROJECTS:

1986-1989 Phase III multicenter study of recombinant human erythropoietin (r-HuEPO) in

correction of anemia of hemodialysis patients. AMGEN [$200,000 ]

1989-1991 A double-blind, placebo-controlled study of recombinant human erythropoietin in

peritoneal dialysis patients. AMGEN [$100,000 ]

1989-1991 Peritoneal function in peritoneal dialysis patients on r-HuEPO. AMGEN

1992 A comparison of blood pressure in peritoneal dialysis and hemodialysis patients

using ambulatory blood pressure monitoring. HOECHST [$10,000]

1994-1997 The effects of normal versus anemic hematocrit on outcomes of cardiac disease in

hemodialysis patients. AMGEN [$75,000]

1994-1997 The echocardiographic effects of normal versus anemic hematocrit on hemodialysis

patients with elevated left ventricular mass index. AMGEN [$16,200]

1995 Quantum PD clinical study. BAXTER HEALTHCARE

1996-1998 Genetic markers for focal glomerulosclerosis. National Institutes of Health (NIH)

2000 A randomized study comparing the efficiency of once vs three times

weekly administration of SC Novel Erythropoietin Stimulating Protein (NESP)

to ESRD patients on hemodialysis. AMGEN [$170,000]

2006-2009 The use of Ferric citrate as a phosphate binder in hemodialysis patients (Keryx)

PATENTS:

1994 #5,301,690-"Device for containing bodily fluid resulting from the occurrence of a rupture or leak

during a medical procedure". E. J. Lewis and S. M. Korbet.

1995 #5,392,786-"Device and method for containing bodily fluid resulting from the occurrence of a

rupture or leak during a medical procedure". E. J. Lewis and S. M. Korbet.

Page - 4

ORGANIZATIONS:

1973 Alpha Epsilon Delta (Honorary Pre-Med Society)

1973 Sigma Zeta (Honorary Science Society)

1975 Phi Kappa Phi (Honorary Scholastic Society)

1979 Alpha Omega Alpha

1980 Associate, American College of Physicians

1983 Member, American College of Physicians

1983 International Society of Nephrology

1983 American Medical Association

1983 Illinois State Medical Society

1983 Chicago Medical Society

1983 New York Academy of Sciences

1984 American Society of Nephrology

1984 Chicago Society of Internal Medicine

1986 Fellow, American College of Physicians

1987 Member, National Kidney Foundation

1989 Renal Physicians Association

1990 American Society of Internal Medicine

1994 American Society for Artificial Internal Organs

1999 American Society of Hypertension Specialist in Clinical Hypertension

2004 Fellow, American Society of Nephrology

2013 Master, American College of Physicians

PARTICIPATION in NATIONAL MEETINGS:

1993 ASN Abstract Reviewer: Clinical Nephrology/Glomerular and Tubular disorders

1993 ASN Free Communication Chair: Nephrotic Syndrome: Course and Treatment


1998 ASN Free Communication Chair: Clinical Nephrology/Glomerular and Tubular disorders

1999 The XIXth Annual CAPD Conference: Moderator: Workshop on Catheter Problems


2006 26th

Annual Dialysis Conference, Nursing home dialysis (Moderator), San Francisco

2007 ASN Abstract Reviewer: Clinical Nephrology/Chronic Kidney Disease

2009 ASN Annual Meeting, The changing face of FSGS/MCD (Moderator), San Diego

2013 ASN Abstract Reviewer: Clinical Glomerular and Tubulointerstitial Disease

2013 ASN Educational Symposium Moderator: Treating “Refractory” Nephrotic Syndrome

JOURNAL EDITORIAL BOARD:

1994-1998 American Journal of Kidney Diseases

1998-2008 Journal of Nephrology

1998-2006 Peritoneal Dialysis International

2007-2013 Journal of the American Society of Nephrology

2005-2013 Clinical Journal of the American Society of Nephrology

Page - 5

PUBLICATIONS:

1. Korbet SM, Schwartz MM, Lewis EJ: Immune complex deposition and coronary vasculitis in

systemic lupus erythematosus: A report of 2 cases. Am J Med 1984; 77:141-146.

2. Korbet SM, Block LJ, Lewis EJ: Laryngeal complications in a patient with inactive systemic lupus

erythematosus. Arch Intern Med 1984; 144:1867-1868.

3. Corwin HL, Korbet SM, Schwartz MM: Clinical correlates of eosinophiluria. Arch Intern Med 1984;

145:1097-1099.

4. Korbet SM, Schwartz MM, Rosenberg BF, Sibley RK, Lewis EJ: Immunotactoid glomerulopathy.

Medicine 1985; 64:228-243.

5. Korbet SM, Corwin HL, Lewis EJ: Transient nephrogenic diabetes insipidus associated with

pregnancy. Am J Nephrol 1985; 5:442-444.

6. Korbet SM, Corwin HL: Pernicious anemia associated with systemic lupus erythematosus. J Rheum

1986; 13:193-194.

7. Korbet SM, Schwartz MM, Lewis EJ: The prognosis of focal segmental glomerular sclerosis of

adulthood. Medicine 1986; 65:304-311.

8. Korbet SM, Corwin HL, Patel SK, Schwartz MM: Intraperitoneal hemmorrhage associated with

systemic lupus erythematosus. J Rheum 1987; 14:398-400.

9. Kasinath BS, Corwin HL, Bidani AK, Korbet SM, Schwartz MM, Lewis EJ: Eosinophilia in the

diagnosis of atheroembolic renal disease. Am J Nephrol 1987; 7:173-177.

10. Firanek CA, Marino KS, Korbet SM: A disconnect option in CAPD:. A convenient alternative for

the patient. Advances in Continuous Ambulatory Peritoneal Dialysis/1987, Peritoneal Dialysis Bulletin,

Inc., 1987, pp 100-104.

11. Rodby RA, Korbet SM, Lewis EJ: The persistence of clinical and serologic activity in systemic lupus

erythematosus patients on peritoneal dialysis. Am J Med 1987; 83:613-618.

12. Korbet SM, Schwartz MM, Lewis EJ: Recurrent nephrotic syndrome in renal allografts. Am J

Kidney Dis 1988; 11:270-276.

13. Korbet SM, Schwartz MM, Lewis EJ: Minimal change disease of adulthood. Am J Nephrol 1988;

8:291-297.

14. Warren GU, Korbet SM, Schwartz MM, Lewis EJ: Minimal change glomerulopathy associated with

nonsteroidal anti-inflammatory drugs. Am J Kidney Dis 1989; 13:127-130.

15. Sankary HN, Foster P, Tuman K, Spiess B, Korbet S, Hart M,and Williams JW: Intraoperative

continuous arterio-venous hemofiltration (CAVH): A method to diminish fluid sequestration during liver

Page - 6

transplant operations. Trans Proc 1989; 21:2326-2327.

16. Korbet SM: Comparison of hemodialysis and peritoneal dialysis in the management of anemia

related to chronic renal disease. Seminars in Nephrology 1989; 9:9-15 suppl 1.

17. Griffin KA, Schwartz MM, Korbet SM: Pulmonary- renal syndrome of bacterial endocarditis

mimicking Goodpasture's syndrome. Am J Kidney Dis 1989; 14:329-332.

18. Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW,

Friedman EA, Graber SE, Haley NR, Korbet SM, Krantz SB, Lundin AP, Nissenson AR, Ogden DA,

Paganini EP, Rader B, Rutsky EA, Stivelman J, Stone WJ, Teschan P, Van Stone JC, Van Wyck DB,

Zuckerman K, Adamson JW: Recombinant human erythropoietin in anemic patients with end-stage renal

disease: Results of a phase III multicenter clinical trial. Ann Intern Med 1989; 111:992-1000.

19. Evans RW, Rader B, Manninen DL, and the Cooperative Multicenter EPO Clinical Trial Group: The

quality of life of hemodialysis patients treated with recombinant human erythropoietin. JAMA 1990;

263:825-830.

20. Korbet SM, Rosenberg BF, Schwartz MM, Lewis EJ: The course of renal transplantation in

immunotactoid glomerulopathy. Am J Med 1990; 89:91-95.

21. Korbet SM, Schwartz MM, Lewis EJ: Immunotactoid glomerulopathy. [Review] Am J Kidney Dis

1991; 17:247-257.

22. Dodhia N, Rodby RA, Jensik SC, Korbet SM: Renal transplant arterial thrombosis: Association with

cyclosporine and multiple renal arteries. Am J Kidney Dis 1991; 17:532-536.

23. Firanek CA, Vonesh EF, Korbet SM: Patient and technique survival among an urban population of

peritoneal dialysis patients: An eight year experience [published erratum appears in Am J Kidney Dis

1992; 19:93]. Am J Kidney Dis 1991; 18:91-96.

24. Burstein DM, Schwartz MM, Korbet SM: Percutaneous renal biopsy with the use of real-time

ultrasound. Am J Nephrol 1991; 11:195-200.

25. Korbet SM, Vonesh EF, Firanek CA: The effect of hematocrit on peritoneal transport. Am J Kidney

Dis 1991; 18:573-578.

26. Korbet SM: The Treatment of Focal Segmental Glomerular Sclerosis: Steroid-resistance or Steroid-

reluctance? [Editorial]. Kidney 1992; 1:2-3.

27. Korbet SM, Schwartz MM: Human immunodeficiency virus infection and nephrotic syndrome.

[clinical conference] Am J Kidney Dis 1992; 20:97-103.

28. Lewis EJ, Korbet SM, Schwartz MM: Immunotactoid glomerulopathy [Letter]. Am J Kidney Dis

1992; 20:198-199.

29. Korbet SM: Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal

dialysis. [Review] Kidney Int 1993; Vol 43, Suppl 40:S111-S119.

Page - 7

30. Korbet SM, Vonesh EF, Firanek CA: A retrospective assessment of risk factors for peritonitis among

an urban population of peritoneal dialysis patients. Perit Dial Int 1993; 13:126-131.

31. Burstein DM, Korbet SM, Schwartz MM: Membranous glomerulonephritis and malignancy. A J

Kidney Dis 1993; 22:5-10.

32. Burstein DM, Korbet SM, Schwartz MM, Lewis EJ: The use of the automatic core biopsy system in

percutaneous renal biopsies. Am J Kidney Dis 1993; 22:545-552.

33. Korbet SM, Makita Z, Firanek CA, Vlassara H: Advanced glycosylation endproducts in continuous

ambulatory peritoneal dialysis patients. Am J Kidney Dis 1993; 22:588-591.

34. Schwartz MM, Korbet SM: Primary focal segmental glomerulosclerosis: Pathology, histologic

variants, and pathogenesis. [Review] Am J Kidney Dis 1993; 22:874-883.

35. Korbet SM, Schwartz MM: An adult with the nephrotic syndrome unresponsive to treatment. Am J

Kidney Dis 1993; 23:148-154.

36. Rodby RA, Vonesh EF, Korbet SM: Blood pressures in hemodialysis and peritoneal dialysis using

ambulatory blood pressure monitoring. Am J Kidney Dis 1994; 23:401-411.

37. Korbet SM, Rodby RA: Peritoneal membrane failure: Causes, diagnosis, and treatment. Seminars in

Dialysis 1994; 7:128-137.

38. Korbet SM, Schwartz MM, Lewis EJ: The fibrillary glomerulopathies. [Review] Am J Kidney Dis

1994; 23:751-765.

39. Korbet SM, Schwartz MM, Lewis EJ: Primary Focal Segmental Glomerulosclerosis: Clinical Course

and Response to Therapy. [Review] Am J Kidney Dis 1994; 23:773-783.

40. Makita Z, Bucala R, Rayfield EJ, Friedman EA, Kaufman AM, Korbet SM, Barth RH, Winston JA,

Fuh H, Manogue KR, Cerami A, Vlassara H: Reactive glycosylation endproducts in diabetic uraemia

and treatment of renal failure. Lancet 1994; 343:1519-1522.

41. Nissenson AR, Korbet SM, Faber M, Burkart J, Gentile D, Hamburger R, Mattern W, Schreiber M,

Swartz R, Van Stone J, Watson A, Zimmerman S: Multicenter trial of EPO in patients on peritoneal

dialysis. J Am Soc Nephrol 1995; 5:1517-1529.

42. Korbet SM, Casey C, Rodby RA, Williams JW: CAVH in orthotopic liver transplantation [Letter].

Clin Nephrol 1995; 43:134-136.

43. Korbet SM: Management of idiopathic nephrotic syndrome in adults, including steroid-resistant

nephrosis. Current Opinion in Nephrology and Hypertension, 1995; 4:169-176.

44. Rydel JJ, Korbet SM, Borok RZ, Schwartz MM: Focal segmental glomerular sclerosis in adults:

Presentation, course and response to treatment. Am J Kidney Dis, 1995; 25:534-542.

Page - 8

45. Schwartz MM, Korbet SM, Rydel JJ, Borok RZ, Genchi R: Focal segmental glomerular sclerosis in

adults: Prognostic value of histologic variants. Am J Kidney Dis, 1995; 26:845-852.

46. Korbet SM, Vonesh EF, Firanek CA.: Peritonitis in an urban dialysis program: An analysis of

infecting pathogens. Am J Kidney Dis, 1995; 26:47-53.

47. Shih DJ, Korbet SM, Rydel JJ, Schwartz MM: Renal vasculitis associated with ciprofloxacin. Am J

Kidney Dis, 1995; 26:516-519.

48. Sloan RP, Schwartz MM, Korbet SM, Borok RZ, Ding D: Long-term outcome in systemic lupus

erythematosus membranous glomerulonephritis. J Am Soc Nephrol, 1996; 7:299-305.

49 Korbet SM, Genchi RM, Schwartz MM: The racial prevalence of glomerular lesions in nephrotic

adults. Am J Kidney Dis, 1996; 27: 647-651.

50. Oreopoulos DG, Korbet SM: Peritoneal Dialysis Case Forum: A patient with ultrafiltration failure.

Perit Dial Int, 1996, 16: 194-201.

51. Marwah D, Korbet S M: Timing of complications in percutaneous renal biopsy: What is the optimal

period of observation? Am J Kidney Dis, 1996; 28: 47-52.

52. Rodby RR, Firanek CA, Cheng YG, Korbet SM: The reproducibility of KT/V measurements.

Kidney Int 1996; 50: 267-271.

53. Blake P, Burkart JM, Curchill DN, Daugirdas J, Depner T, Hamburger RJ, Hull AR, Korbet SM,

Moran JE, Nolph KD, Oreopoulos DG, Schreiber M, Soderbloom RE. Recommended clinical practices

for maximizing peritoneal dialysis clearances. Perit Dial Int, 1996; 16: 448-456.

54. Burkart JM, Schreiber MJ, Korbet SM, Churchill DN, Hamburger RJ, Moran JE, Soderbloom RE,

Nolph KD: Solute clearance approach to adequacy of peritoneal dialysis. Perit Dial Int, 1996; 16: 457-

470.

55. Korbet SM: Peritonitis: Finding success by evaluating the failures. Journal of Artifical Organs

[editorial] 1996, 19: 695-696.

56. Michell T, Villano R, Burkart J, Korbet S, Pagè D, Strauss F: Prospective evaluation of a night

exchange system in stable peritoneal dialysis patients. Dialysis & Transplantation, 1997; 26: 80-89.

57. Korbet SM: Primary focal segmental glomerulosclerosis [Disease of the Month]. J Am Soc Nephrol,

1998; 9:1333-1340.

58. Korbet SM: Work-up of ultrafiltration failure. [Review] Advances in Renal Replacement Therapy,

1998; 5: 194-204.

59. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ Goodkin

DA: The effects of norml versus low hematocrit values in hemodialysis patients with cardiac diseases.

New Engl J Med, 1998; 339:584-590. (Principle Investigator-Rush Medical College).

Page - 9

60. Odama UO, Shih DJ, Korbet SM: Sclerosing Peritonitis and Systemic Lupus Erythematosus: A

Report of Two Cases. Perit Dial Int; 1999, 19:160-164.

61. Korbet SM: Clinical picture and outcome of primary focal segmental glomerulosclerosis. [Review]

Nephrology, Dialysis and Transplantation, 1999, 14 [Suppl. 3]: 68-73.

62. Schwartz MM, Evans J, Bain R, Korbet SM: The cellular lesion of focal segmental

glomerulosclerosis: Therapeutic response and prognosis. J Am Soc Nephrol, 1999, 10:1900-1907.

63. Korbet SM, Shih D, Cline KN, Vonesh EF: Racial differences in survival in an urban peritoneal

dialysis program. Am J Kidney Dis, 1999, 34:713-720.

64. Blake P, Korbet SM, Blake R, Bargman J, Burkart J, Delano B, Dasgupta M, Fine A, Finkelstein F,

McCusker F, McMurray S, Zebatakis P, Zimmerman S: Admitted noncompliance with CAPD exchanges

is more common in US than Canadian patients. Am J Kidney Dis, 2000, 35:506-514.

65. Shah DR, Hoeksema J, Korbet SM: Multiple renal tumors in a young man with cystic kidneys. Clin

Nephrol, 2000, 53:216-221.

66. Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD, for the Collaborative Study

Group: Factors predictive of outcome in severe lupus nephritis. Am J Kidney Dis, 2000, 35:904-914.

67. Kim GC, Korbet SM: Polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients.

Am J Kidney Dis, 2000, 36:1000-1008.

68. Tanna MM, Vonesh EF, Korbet SM: Patient survival among incident peritoneal dialysis and

hemodialysis patients in an urban setting. Am J Kidney Dis, 2000, 36:1175-1182.

69. Mujias S, Nolph K, Gokal R, Blake P, Burkart J, Coles G, Kawaguchi Y, Kawanishi H, Korbet S,

Krediet R, Lindholm B, Oreoplulos D, Rippe B, Selgas R, for the International Society for Peritoneal

Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis: Evaluation and

management of ultrafiltration problems in peritoneal dialysis. Perit Dial Int; 2000, 20 [Suppl 4]:S5-S21.

70. Colattur SN, Korbet SM: Long-term outcome of adult onset minimal change disease. Saudi Journal

of Kidney Diseases and Transplantation, 2000,11:334-344.

71. Blake PG, Breborowicz A, Han DS, Joffe P, Korbet SM, Warady BA: Recommended peritoneal

dialysis curriculum for nephrology trainees. The International Society for Peritoneal Dialysis Standards

and Education Subcommittee. Perit Dial Int; 2000,20:497-502.

72. Korbet SM: The treatment of primary focal segmental glomerulosclerosis. Renal Failure, 2000,

22:685-696.

73. National Kidney Foundation: NKF-K/DOQI Clinical Practice guidelines for peritoneal dialysis

adequacy, 2000. Am J Kidney Dis, 2001, 37 [Suppl 1]:S65-S136.

74. Najafi CC, Hertko L, Leikin, Korbet SM: Fomepizole in ethylene glycol intoxication. [Letter] Ann

Emerg Med, 2001, 37(3):358-359.

Page - 10

75. Korbet SM, Schwartz MM: Primary Focal Segmental Glomerulosclerosis: A treatable lesion with

variable outcomes. Nephrology, 2001, 6(2):47-56.

76. Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD, for the Lupus

Nephritis Collaborative Study Group: The long-term outcome of severe lupus nephritis based on

histologic categorization. Kidney Int, 2001, 59(6):2156-2163.

77. Lewis EJ, Schwartz MM, Korbet SM: Severe Lupus Nephritis: Importance of re-evaluating the

histologic classification and the approach to patient care. Journal of Nephrol, 2001, 14:223-227.

78. Schwartz MM, Korbet SM, Lewis EJ: Immunotactoid glomerulopathy [Disease of the Month]. J Am

Soc Nephrol, 2002, 13: 1390-1397.

79. Kim GC, Vonesh GF, Korbet SM: The effect of technique failure on outcome in Black patients on

continuous ambulatory peritoneal dialysis. Perit Dial Int, 2002, 22:53-59.

80. Korbet SM: Percutaneous renal biopsy [Review]. Seminars in Nephrology, 2002, 22:254-267.

81. Korbet SM: Primary focal segmental glomerulosclerosis: Treatment. Quarterly Journal of the

Hellenic Society of Nephrology, 2002, 14(Suppl 2002):109-112.

82. Korbet SM: Treatment of primary focal segmental glomerular sclerosis. [Nephrology Forum]

Kidney Int, 2002, 62:2301-2310.

83. Korbet SM: Angiotensin antagonists and steroids in the treatment of focal segmental

glomerulosclerosis [Review]. Seminars in Nephrology, 2003, 23:219-228.

84. Whittier WL, Korbet SM: The timing of complications in percutaneous renal biopsy. J Am Soc

Nephrol, 2004, 15:142-147.

85. Chun MJ, Korbet SM, Schwartz MM, Lewis EJ: Focal segmental glomerulosclerosis in nephrotic

adults: Presentation, prognosis and response to therapy of the histologic variants. J Am Soc Nephrol,

2004, 15:2169-2177.

86. Whittier WL, Korbet SM: Perctaneous renal biopsy: update. Current Opinions in Nephrology, 2004,

13:661-665.

87. Kraft SW, Schwartz MM, Korbet SM, Lewis EJ: Glomerular podocytopathy in patients with

systemic lupus erythematosus. J Am Soc Nephrol, 2005, 16:175-179.

88. Schlieben DJ, Korbet SM, Kimura RE, Schwarz MM, Lewis EJ,: Placental transmission of

antineutrophil cytoplasmic antibodies. Am J Kidney Dis, 2005, 45:758-761. Erratum, 2005, 46:171.

89. Orloff MS, Iyengar SK, Winkler CA, Goddard KAB, Dart RA, Ahuja TS, Mokrzycki M, Briggs

WA, Korbet SM, Kimmel PL, Simon EE, Trachtman H, Vlahov D, Michel DM, Berns JS, Smith MC,

Schelling JR, Sedor JR, Kopp JB: Variants in the Wilms’ tumor gene are associated with focal

segmental glomerulosclerosis in the African American population. Physiol Genomics, 2005, 21:212-221.

Page - 11

90. Korbet SM, Schwartz MM: Multiple Myeloma. J Am Soc Nephrol, 2006, 17:2533-2545.

91. Korbet SM, Schwartz MM, Lewis EJ: Immunotactoid Glomerulopathy. Clin J Am Soc Nephrol,

2006, 1:1351-1356.

92. Korbet SM, Schwartz MM, Evans J, Lewis EJ: Severe lupus nephritis: Racial differences in

presentation and outcome. J Am Soc Nephrol, 2007, 18:244-254.

93. Reddy N, Korbet SM, Wozniak JA, Floramo SL, Lewis EJ: Staff-assisted nursing home

hemodialysis: patient characteristics and outcomes. Nephrol Dial Transplant, 2007, 22(5):1399-1406;

doi:10:1093.

94. Rovin BH, Roncone D, McKinley A, Nadasdy T, Korbet SM, Schwartz MM: Identification of the

apolipoprotein E Kyoto mutation in European Amerricans with lipoprotein glomerulopathy. New Engl J

Med, 2007, 357:2522-2524.

95. McKenzie LM, Hendrickson SL, Briggs WA, Dart RA, Korbet SM, Mokrzycki M H, Kimmel PL,

Ahuja TS, Berns JS, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Cho M, Zhou YC,

Binns-Roemer E, Kirk GD, Kopp JB, Winkler CA: NPHS2 variation in sporadic FSGS. J Am Soc

Nephrol, 2007, 18:2987-2995.

96. Chen YE, Korbet SM, Katz RS, Schwartz MM, Lewis EJ: The value of a partial remission in severe

lupus nephritis. Clin J Am Soc Nephrol, 2008, 3:46-53.

97. Schwartz MM, Korbet SM, Lewis EJ: The prognostic and pathogenetic significance of severe focal

segmental lupus glomerulonephritis. Nephrol Dial Transplant, 2008, 23:1298-1306.

98. Korbet SM, Bonsib S: A case of polyneuropathy and proteinuria. Clin J Am Soc Nephrol, 2008,

3:624-636.

99. Concepcion B, Korbet SM, Schwartz MM: Intravascular hemolysis and acute renal failure after

mitral and aortic valve repair. Am J Kidney Dis, 2008, 52:1010-1015.

100. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Olesyk T, McKenzie

LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel

DM, Mokrzycki MH, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA: MYH9 is a major-

effect risk gene for focal segmental glomerulosclerosis. Nat Genet 40:1175-1184, 2008.

101. Schwartz MM, Korbet SM, Katz RS, Lewis EJ: Evidence of concurrent immunopathologic

mechanisms determining the pathology of severe lupus nephritis. Lupus, 2009, 18:149-158.

102. Waldo B, Korbet SM, Freimanis MG, Lewis EJ: The value of post-biopsy ultrasound in predicting

complications after percutaneous renal biopsy of native kidneys. Nephrol Dial Transplant, 2009,

24:2433-2439.

103. Korbet SM, Waldo B, Freimanis MG, Lewis EJ: The value of post-biopsy ultrasound in predicting

complications after percutaneous renal biopsy of native kidneys. Nephrol Dial Transplant [Reply] 2010,

25:317-318.

Page - 12

104. Behara VY, Whittier WL, Korbet SM, Schwartz MM, Martens M, Lewis EJ: Pathogenic features of

severe segmental lupus nephritis. Nephrol Dial Transplant, 2010, 25:153-159.

105. Patel SB, Korbet SM, Lewis EJ: The prognosis of severe lupus nephritis based on the MDRD-GFR

at biopsy. Lupus, 2011, 20: 256-264.

106. Patel UO, Fox SR, Moy JN, Korbet SM: Pruritic rash and eosinophilia in a patient on peritoneal

dialysis. Semin Dial, 2011, 24:338-440.

107. Yau TY, Korbet SM, Schwartz MM, Cimbaluk DJ: Use of the Oxford classification of IgA

nephropathy top predict outcome: A retrospective analysis. Am J Nephrol, 2011, 34:435-444.

108. Kopp JB, Nelson G, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R,

Korbet S, Mokrzycki M, Kimmel PL, Limou S, Ahuja TS, Berns JS, Simon E, Smith MC, Trachtman

H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA: APOL1 genetic variants in focal

segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol, 2011, 22:2129-2137.

109. Korbet SM, Lewis EJ: Complete remission in severe lupus nephritis: Assessing the rate of loss in

proteinuria. Nephrol Dial Transplant, 2012, 27:2813-2819.

110. Korbet SM: Nephrology and the percutaneous renal biopsy: A procedure in jeopardy of being lost

along the way. Editorial, Clin J Am Soc Nephrol, 2012, 7:1545-1547.

111. Sinsakul M, Sika M, Koury M, Shapiro W, Greene T, Dwyer J, Smith M, Korbet S, Lewis J for the

Collaborative Study Group: The Safety and Tolerability of ferric citrate as a phosphate binder in dialysis

patients. Nephron Clinical Practice, 2012, 121:c25-c29.

112. Korbet SM: Brief Review: Treatment of primary focal segmental glomerulosclerosis in adults. J

Am Soc Nephrol, 2012, 23:1769-1776.

113. Korbet SM, Lewis EJ: Severe Lupus Nephritis: The predictive value of a >50% reduction in

proteinuria at 6 months. Nephrol Dial Transplant, 2013, 28:2313-2318.

114. Raju P, Cimbaluk DJ, Korbet SM: The variable course of women with X-linked Alport syndrome.

Clin Kidney J, 2013, 6:630-634.

115. Korbet SM, Volpini KC, Whittier WL: Percutaneous renal biopsy of native kidneys: A single-

center experience of 1,055 biopsies. Am J Nephrol, 2014, 39:153-162.

116. Whittier WL, Korbet SM: Who should perform the percutaneous renal biopsy: Nephrologists or

Radiologists? Semin Dial, 2014, 27:243-245.

117. Chunduri S, Whittier WL, Korbet SM: Adequacy and Complication rates with 14 vs. 16-gauge

automated needles in Percutaneous Renal Biopsy of Native Kidneys. Semin Dial, 2015, 28:E11-14.

118. Sahota S, Rodby RS, Korbet SM: Cystain-C in the evaluation of chronic kidney disease.

Nephrology, 2015, 20:383-384.

Page - 13

119. Whittier WL, Sayeed K, Korbet SM: Clinical factors influencing the decision to transfuse after

percutaneous native kidney biopsy. Clin Kidney J, 2016, 9:102-107.

120. Korbet SM, Whittier WL, Lewis EJ: The impact of baseline serum creatinine on complete

remission rate and long-term outcome in patients with severe lupus nephritis. Nephron EXTRA, 2016,

6:12-21.

BOOK CHAPTERS:

1. Korbet SM, Lewis EJ: Glomerulonephritis and the nephrotic syndrome, in "Current Nephrology

Volume 9", Gonick HC, editor, Year Book Medical Publishers, Chicago, Il., 1986, pp 209-247.

2. Korbet SM, Lewis EJ: Cryoimmunoglobulinemia, in "Current Therapy in Nephrology and

Hypertension-2", Glassock RS, editor, BC Decker, Inc., Philadelphia, Pa., 1987, pp 142-144.

3. Korbet SM: Kidney, in "The World Book Health and Medical Annual", Zeleny RO, editor, World

Book, Inc. Chicago, Il., 1988; pp 289-290.

4. Schwartz MM, Korbet SM: Crescentic glomerulonephritis, in Progress in Genito-urinary Pathology,

Damjanov I, editor, Field and Wood Medical Publishers, Inc., 1989; pp 163-195.

5. Korbet SM: Kidney, in "The World Book Health and Medical Annual", Zeleny RO, editor, World

Book, Inc. Chicago, Il., 1989; pp 307-308.

6. Schwartz MM, Korbet SM, Lewis EJ: The value of the renal biopsy, in "Contemporary Issues in

Nephrology, Volume 25; Diagnostic Techniques in Renal Disease", R G Narins and J H Stein, editors,

Churchill Livingstone, New York, 1992, pp 269-304.

7 Rodby RA, Korbet SM: Causes, diagnosis, and treatment of peritoneal membrane failure, in

"Principles and Practice of Dialysis", W L Henrich, editor, Williams and Wilkins, Baltimore, 1994, pp

130-147.

8. Korbet SM: Chronic renal failure. in "Quick Reference to Internal Medicine", R Bone, editor, Agiku-

Shoin, 1994, Chapter 86, pp 1115-1127.

9. Korbet SM: Nephrotic syndrome and glomerulonephritis. in "Quick Reference to Internal Medicine",

R Bone, editor, Agiku-Shoin, 1994, Chapter 89, pp 1143-1148.

10. Korbet SM: Renal disorders associated with systemic diseases. in "Quick Reference to Internal

Medicine", R Bone, editor, Agiku-Shoin, 1994, Chapter 90, pp 1149-1154.

11. Korbet SM, Schwartz MM, Lewis EJ: Immunotactoid glomerulopathy, in "The Textbook of

Nephrology" SG Massry and RJ Glassock, editors, Williams and Wilkins, Baltimore, 1994, Chapter

41.10, pp 746-749.

12. Korbet SM: Primary glomerular diseases. in "Conn's Current Therapy", R. E. Rakel, editor, W. B.

Saunders, Philadelphia, 1997, pp 667-679.

Page - 14

13. Schwartz MM, Korbet SM: Amyloidosis and the dysproteinemias. in "Immunologic Renal

Diseases", EG Neilson and W G Couser, editors, Raven Press, New York, 1997, pp 1147-1159.

14. Korbet SM: Obstructive Uropathy, in "NKF Primer on Kidney Diseases, 2nd Edition" A Greenberg,

editor, Academic Press, 1997, Chapter 54, pp 348-356.

15. Korbet SM,: Focal Segmental Glomerulosclerosis, in "Current Therapy in Nephrology and

Hypertension-4", Glassock RS, editor, BC Decker, Inc., Philadelphia, Pa., 1998, 196-200.

16. Lewis EJ, Obasi E, Korbet SM: Immutactoid Glomerulopathy, in "Current Therapy in Nephrology

and Hypertension-4th edition", Glassock RS, editor, BC Decker, Inc., Philadelphia, Pa., 1998, pp 220-

222.

17. Korbet SM: Primary Focal Segmental Glomerulosclerosis, in "Therapy in Nephrology and

Hypertension: A Companion to Brenner and Rector's The Kidney" HR Brady and CS Wilcox, editors,

W. B. Saunders, Philadelphia, 1998, Chapter 25, pp 178-188.

18. Korbet SM, Rodby RA: Causes, diagnosis, and treatment of peritoneal membrane failure, in

"Principles and Practice of Dialysis, Second Edition", W L Henrich, editor, Williams and Wilkins,

Baltimore, 1998, Chapter 13, pp 185-206.

19. Korbet SM: Membranous lupus glomerulonephritis, in "Lupus Nephritis" EJ Lewis, MM Schwartz

and SM Korbet, editors, Oxford University Press, Oxford, 1999, Chapter 8, pp 219-240.

20. Korbet SM, Kronfol NO: Acute Peritoneal Dialysis, in "Handbook of Dialysis, Third Edition",

Daugirdas JT, Blake PG, and Ing TS, editors, Lippincott Williams and Wilkins, Philadelphia, 2001,

Chapter 16, pp 333-342.

21. Korbet SM,: Focal and segmental glomerulosclerosis, in "The Textbook of Nephrology, Fourth

Edition" SG Massry and RJ Glassock, editors, Lippincott, Williams and Wilkins, Baltimore, 2001,

Chapter 39, Part 5, pp 699-706.

22. Korbet SM: Obstructive Uropathy, in "NKF Primer on Kidney Diseases, 3rd Edition" A Greenberg,

editor, Academic Press, 2001, Chapter 51, pp 336-344.

23. Schwartz MM, Korbet SM: Amyloidosis and the dysproteinemias. in "Immunologic Renal Diseases,

2nd Edition", EG Neilson and W G Couser, editors, Raven Press, New York, 2001, Chapter 48, pp

1155-1173.

24. Korbet SM: Primary Focal Segmental Glomerulosclerosis, in "Therapy in Nephrology and

Hypertension: A Companion to Brenner and Rector's The Kidney, 2nd Edition" HR Brady and CS

Wilcox, editors, W. B. Saunders, Philadelphia, 2003, Chapter 23, pp 223-236.

25. Korbet SM, Rodby RA: Causes, diagnosis, and treatment of peritoneal membrane failure, in

"Principles and Practice of Dialysis, Third Edition", W L Henrich, editor, Lippincott Williams and

Wilkins, Philadelphia, 2003, Chapter 15, pp 206-226.

Page - 15

26. Korbet SM, Schwartz MM, Lewis EJ: Immunotactoid Glomerulopathy, in "Oxford Textbook of

Clinical Nephrology, 3rd Edition" Davison et al, editors, Oxford University Press, Oxford UK, 2005,

Chapter 4.2.2, pp 702.

27. Whittier W, Korbet SM: Obstructive Uropathy, in "NKF Primer on Kidney Diseases, 4th Edition" A

Greenberg, editor, Academic Press, 2005, Chapter 51, pp 389-398.

28. Korbet SM: Acute Peritoneal Dialysis, in "Handbook of Dialysis, Fourth Edition", Daugirdas JT,

Blake PG, and Ing TS, editors, Lippincott Williams and Wilkins, Philadelphia, 2007, Chapter 21, pp

376-386.

29. Schwartz MM, Korbet SM: Pathology, pathogenesis and clinical features of severe lupus nephritis,

in "Lupus Nephritis 2e" EJ Lewis, MM Schwartz and SM Korbet, editors, Oxford University Press,

Oxford, 2010, Chapter 6, pp 129-167.

30. Korbet SM, Schwartz MM, Lewis EJ: Fibrillary and Immunotactoid Glomerulopathy, in "Oxford

Textbook of Clinical Nephrology, 4th Edition" Turner et al, editors, Oxford University Press, Oxford

UK, 2015, Chapter 81.

31. Whittier WL, Gashti C, Korbet SM: Focal Segmental Glomerulosclerosis in “Glomerulonephritis”,

H Trachtman, JJ Hogan, L Herlitz and EV Lerma editors. Springer Publishing Company, 2017

BOOKS EDITED:

1. "Lupus Nephritis" EJ Lewis, MM Schwartz and SM Korbet, editors, Oxford University Press,

Oxford, 1999.

2. "Lupus Nephritis 2e" EJ Lewis, MM Schwartz and SM Korbet, editors, Oxford University Press,

Oxford, 2010.

Online Publications:

1. Whittier WL, Korbet SM: Indications and complications of renal biopsy. Up To Date section author

Page - 16

ABSTRACTS AND PRESENTATIONS:

1. S.M. Korbet, M.M. Schwartz, B.F. Rosenberg, R.K. Sibley, E.J. Lewis: Immunotactoid

glomerulopathy. Presented-IX International Congress of Nephrology, June 14, 1984. Proceedings of the

IXth International Congress of Nephrology 1984, 287A .

2. S.M. Korbet, M.M. Schwartz, E.J. Lewis: The prognosis of focal segmental glomerular sclerosis of

adulthood. Presented-American Society of Nephrology 18th Annual Meeting. Kidney Int 1986; 29:193

(abst).

3. S.M. Korbet, C. Firanek, E.J. Lewis: A comparative study of ambulatory peritoneal dialysis

modalities. National Kidney Foundation 15th Annual Meeting, December 13-15, 1985. Am J Kidney Dis

1985; A8 (abst).

4. S.M. Korbet, M.M. Schwartz, E.J. Lewis: Minimal change disease of adulthood. American Society of

Nephrology 19th Annual Meeting. Kidney Int 1987; 31:206 (abst).

5. R. Rodby, S. Korbet, E. Lewis: The persistence of clinical and serologic activity in systemic lupus

erythematosus patients on chronic peritoneal dialysis. American Society of Nephrology 19th Annual

Meeting. Kidney Int 1987; 31:254 (abst).

6. G.V. Warren, S.M. Korbet, M.M. Schwartz, E.J. Lewis: Variable pathology and long-term follow-up

of minimal change disease associated with nonsteroidal anti-inflammatory drugs. American Society of

Nephrology 19th Annual Meeting. Kidney Int 1987; 31:223 (abst).

7. C.A. Firanek, K.S. Marino, S.M. Korbet: A disconnect option in CAPD: A convenient alternative for

the patient. CAPD 7th National Symposium. Peritoneal Dial Bul 1987; 6:S7 (abst).

8. E.J. Lewis, B. McLeod, R. Katz, S. Korbet, T. Schnitzer, W. Wong, A. Neighbour: Clinical

application of a specific immunoadsorption column for the removal of anti-native DNA utilizing

monoclonal anti-idiotype antibodies. American Society of Nephrology 20th Annual Meeting. Kidney Int

1988; 33:199 (abst).

9. J.W. Eschbach, and J.W. Adamson for the Cooperative Multicenter EPO Clinical Trial Group:

Correction of the anemia of hemodialysis patients with recombinant human erythropoietin (r-HuEPO):

Results of a multicenter study. American Society of Nephrology 20th Annual Meeting. Kidney Int 1988;

33:180 (abst).

10. B. McLeod, E. Lewis, T. Schnitzer, R. Katz, S. Korbet, A. Neighbor, W. Wong: Therapeutic

immunoadsorption of anti-native DNA antibodies in SLE: Clinical studies with a device utilizing

monoclonal anti-idiotypic anti-body. American Rheumatism Association, May 23-28, 1988.

11. S.M. Korbet, R. A. Rodby, E.J. Lewis: Anemia of chronic renal failure: A comparison of patients on

ambulatory peritoneal dialysis versus hemodialysis. American Society of Nephrology 21st Annual

Meeting. Kidney Int 1989; 35:196 (abst).

12. R.A. Rodby, S.M. Korbet, E.J. Lewis: Chronic ambulatory peritoneal dialysis as an alternative to

Page - 17

hemodialysis for patients with end-stage renal disease secondary to multiple myeloma. American Society

of Nephrology 21st Annual Meeting. Kidney Int 1989; 35:199 (abst).

13. S. Korbet, C. Firanek: Ambulatory peritoneal dialysis: An inner city experience. American Society of

Nephrology 22nd Annual Meeting. Kidney Int 1990; 37:330 (abst).

14. N. Dodhia, R.A. Rodby, S.C. Jensik, S.M. Korbet: Cyclosporine A associated renal allograft arterial

thrombosis. American Society of Nephrology 22nd Annual Meeting. Kidney Int 1990; 37:605 (abst).

15. D.M. Burstein, M.M. Schwartz, S.M. Korbet: Percutaneous renal biopsy with the use of real-time

ultrasound. National Kidney Foundation Annual Meeting.

16. S.M. Korbet, E.F. Vonesh, C. Firanek: Patient and technique survival among an inner city population

of peritoneal dialysis patients: An eight year experience. American Society of Nephrology 23nd Annual

Meeting. JASN 1990; 1:388 (abst).

17. A.R. Nissenson, R. Swartz, S. Zimmerman, A. Watson and the Epogen Study Group: A double-

blind, placebo-controlled study of recombinant human erythropoietin in peritoneal dialysis patients.

American Society of Nephrology 23nd Annual Meeting. JASN 1990; 1:405 (abst).

18. S.M. Korbet, E.F. Vonesh, C.A. Firanek: The effect of increasing hematocrit on peritoneal transport.

11th Annual Conference on Peritoneal Dialysis. Perit Dial Int, 1991; 11:143 suppl 1 (abst).

19. S.M. Korbet, E.F. Vonesh, C.A. Firanek: Peritonitis among an urban population of peritoneal

dialysis patients. American Society of Nephrology 24th Annual Meeting. JASN 1991; 2:363 (abst).

20. L.W. Assad, S.M. Korbet, M.M. Schwartz: The pathogenesis of crescents in membranous

glomerulonephritis. JASN 1991; 2:588 (abst).

21. Z. Makita, R. Bucala, A. Kauffman, S. Korbet, R. Barth, E. Friedman, J. Winston, J. Cheigh, K.

Stenzel, E. Rayfield, H. Vlassara: Serum advanced glycosylation endproducts (AGEs) in diabetic

nephropathy: Effect of different modes of dialysis and transplantation. Clinical Research 1992; 40:391

(abst).

22. Z. Makita, R. Bucala, E. Rayfield, E. Friedman, A. Kauffman, S. Korbet, R. Barth, J. Winston, H.

Fuh, H. Vlassara: Efficiency of removal of circulating advanced glycosylation end products and mode of

treatment in patients with ESRD. American Society of Nephrology 25th Annual Meeting. JASN 1992;

3:335 (abst).

23. S. Korbet, Z. Makita, C. Firanek, H. Vlassara: Advanced glycosylation endproducts in CAPD

patients. 13th Annual Conference on Peritoneal Dialysis. Perit Dial Int 1993; 13:80 Suppl 1 (abst).

24. R. Rodby, S. Korbet, E. Vonesh: A comparison of blood pressure in peritoneal dialysis and

hemodialysis patients using ambulatory blood pressure monitoring. 13th Annual Conference on

Peritoneal Dialysis. Perit Dial Int 1993; 13:80 Suppl 1 (abst).

25. S.M. Korbet, J. Rydel, M.M. Schwartz, E.J. Lewis: The prognosis of focal segmental glomerular

sclerosis in adults. American Society of Nephrology 26th Annual Meeting. JASN 1993; 4:280 (abst).

Page - 18

26. Korbet S, Vonesh E, Firanek C: Peritonitis in an urban PD program: Analysis of pathogens. 15th

Annual Conference on Peritoneal Dialysis. Perit Dial Int 1995; 15:28 Suppl 1 (abst).

27. Korbet S, Vonesh E, Firanek C: Pathogens causing peritonitis in an urban PD program. 7th Congress

of the International Society for Peritoneal Dialysis. Perit Dial Int 1995; 16: Suppl 1 (abst).

28. Genchi RM, Korbet SM, Schwartz MM: The prevalence of glomerular lesions in nephrotic adults.

XIIIth International Congress of Nephrology, Madrid, Spain, 1995.

29. Tucker WF, Jansen D, Korbet SM, Jacobs JJ: High complication rate following hip arthroplasty in

patients on dialysis. American Academy of Orthopaedic Surgeons 1996 Annual Meeting.

30. Marwah D, Korbet S: Timing of complications in percutaneous renal biopsy: What is the optimal

period of observation? American Society of Nephrology 28th Annual Meeting. JASN 1995; 6:427

(abst).

31. Rodby RR, Firanek CA, Cheng YG, Korbet SM: The reproducibility of KT/V measurements. 16th

Annual Conference on Peritoneal Dialysis. Perit Dial Int 1996;16:S30 (abst)

32. Burkart J, Schreiber M, Tabor T, Korbet S, Stallard R and the PD Collaborative Group: Prospective

multicenter evaluation of patient transfer from PD to HD in 1995. 16th Annual Conference on Peritoneal

Dialysis. Perit Dial Int 1996; 16:S66 (abst)

33. Schreiber M, Stallard R, Burkart J, Korbet S, and the PD Collaborative Group: Peritonitis, a major

reason for transfer from peritoneal dialysis to hemodialysis. 15th Annual Conference on Peritoneal

Dialysis. Perit Dial Int 1996; 16:S36 (abst)

34. Schlichting L, Stallard R, Clark W, Burkart J, Korbet S, Page' D, Strauss F: Quantum PDTM

night

exchange system: Clinical study/Test market evaluation. 17th Annual Conference on Peritoneal Dialysis.

Perit Dial Int 1997.

35. Blake PG, Korbet S, Blake R, Bargman J, Burkart J, Dasgupta M, Delano B, Fine A, Finkelstein F,

McCusker FX: Admitted noncompliance with CAPD exchanges is more common in US than Canadian

patients. Canadian Society of Nephrology, 1997

36. Schwartz MM, Korbet SM: The cellular lesion of focal segmental glomerulosclerosis: Therapeutic

response and prognosis. American Society of Nephrology 30th Annual Meeting. JASN 1997; 8:98A

(abst).

37. Blake PG, Korbet S, Blake R, Bargman J, Burkart J, Dasgupta M, Delano B, Fine A, Finkelstein F,

McCusker F: Admitted noncompliance with CAPD exchanges is more common in US than Canadian

patients. American Society of Nephrology 30th Annual Meeting. JASN 1997; 8:278A (abst).

38. Blake P, Korbet S, Blake R, Bargman J, Burkart J, Dasgupta M, Delano B, Fine A, Finkelstein F,

McCusker F, McMurray S, Zebatakis P, Zimmerman S: Admitted noncompliance with CAPD exchanges

is more common in US than Canadian patients. 18th Annual Conference on Peritoneal Dialysis. Perit

Page - 19

Dial Int 1998; 18: Suppl 1, S12 (abst).

39. Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, for the Lupus Nephritis Collaborative

Study Group: The induction of a renal remission predicts long-term survival of severe lupus nephritis.

American Society of Nephrology 31st Annual Meeting. JASN 1998; 9:93A (abst).

40. Shih D, Cline KN, Firanek CA, Vonesh, Korbet SM: Racial differences in survival in an urban

peritoneal dialysis program. American Society of Nephrology 31st Annual Meeting. JASN 1998;

9:226A (abst).

41. Blake P, Korbet S, Blake R, Bargman J, Burkart J, Dasgupta M, Delano B, Fine A, Finkelstein F,

McCusker F, McMurray S, Zebatakis P, Zimmerman S: Characteristics of CAPD patients who admit

noncompliance. American Society of Nephrology 31st Annual Meeting. JASN 1998; 9:293A (abst).

42. Kopp JB, Vlahov D, Macalino G, Briggs III WA, Korbet SM, Berns JS, Kimmel PL, Welch TR,

Smith MC, Schelling JR, Simon E, Nachman PH, Hutchison F, Rao TKS, Ripley E, Wachter L, Nelson

G, Winkler C: Candidate gene analysis in focal segmental glomerulosclerosis among African-

Americans. American Society of Nephrology 31st Annual Meeting. JASN 1998; 9:390A(abst).

43. Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD, for the Lupus

Nephritis Collaborative Study Group: The long-term outcome of severe lupus nephritis based on

histologic categorization. American Society of Nephrology 32nd Annual Meeting. JASN 1999; 10:111A

(abst).

44. Tanna MM, Vonesh EF, Korbet SM: Patient survival among incident peritoneal dialysis and

hemodialysis patients in an urban setting. American Society of Nephrology 32nd Annual Meeting.

JASN 1999; 10:257A (abst).

45. Kopp JB, Branton MH, Briggs III WA, Vlahov D, Korbet SM, Kimmel PL, Dart RA, Berns JS,

Welch TR, Smith MC, Schelling JR, Simon EE, Wachter L, Nelson G, Winkler C: Genetic analysis of

focal segmental glomerulosclerosis among African-Americans. American Society of Nephrology 32nd

Annual Meeting. JASN 1999, 10:437A (abst).

46. GC Kim, SM Korbet: Polymicrobial periotnitis in CAPD patients. American Society of Nephrology

33rd Annual Meeting. JASN 2000; 11: 211A (abst).

47. JB Kopp, MH Branton, WA Briggs III, D Vlahov, RA Dart, SM Korbet, M Mokrzycki, PL Kimmel,

JR Schelling, TS Ahuja, JS Berns, MC Smith, EE Simon, RB Mannon, H Trachtman, G Nelson, J

Whitesell, Winkler C: TGF-Beta1 polymorphisms among African Americans with focal segmental

glomerulosclerosis. American Society of Nephrology 33rd Annual Meeting. JASN 2000, 11:89A (abst).

48. Najafi CC, Korbet SM, Hertko L, Burda AM, Leikin AM: Use of fomepizole to avoid hemodialysis.

2000 NACCT meeting. Clinical Toxicology 2000, 38: 540A (abst).

49. GC Kim, SM Korbet: The effect of technique failure on outcome in Black CAPD patients.

American Society of Nephrology 34th Annual Meeting. JASN 2001; 430A (abst).

50. S.K. Iyengar, S.M. Orloff, W. Briggs, R. Dart, S. Korbet, M. Mokryzcki, D. Vlahov, P. Kimmel, T.

Page - 20

Ahuja, J. Berns, E. Simon, M. Smith, H. Trachtman, M. Michel, C. Winkler, J.R. Schelling, J.R. Sedor,

J.B. Kopp: The Arginine to Tryptophan Mutation in Codon 394 of the Wilms' Tumor Gene (R394W), a

Mutation Hotspot for Denys-Drash (DDS) and Frasier Syndromes (FS), Is Uncommon in Primary

Sporadic Focal Segmental Glomerulosclerosis (FSGS). American Society of Nephrology 34th Annual

Meeting. JASN 2001; 816A (abst).

51. GB Green, J Kim, CA Winkler, A. Koziell, MR Pollak, JB Kopp, WA Briggs, RA Dart, SM Korbet,

M Mokrzycki, PL Kimmel, JR Schelling, TS Ahuja, JS Berns, MC Smith, EE Simon, H Trachtman, AS

Shaw: Genetic polymorphisms in CD2AP are common in patients with glomerular disease . American

Society of Nephrology 35th Annual Meeting. JASN 2002; 39A (abst).

52. WL Whittier, SM Korbet: The timing of complications in percutaneous renal biopsy. American

Society of Nephrology 35th Annual Meeting. JASN 2002; 457A (abst).

53. MJ Chun, MM Schwartz, SM Korbet: Focal segmental glomerulosclerosis: Presentation and course

in pts with classic scars, cellular and tip lesions. American Society of Nephrology 35th Annual Meeting.

JASN 2002; 656A (abst).

54. L Anderson, M Sinsakul, S Korbet, M Schwartz: Membranous glomeulonephritis with segmental

necrosis and/or crescents. JASN 2002; 660A (abst).

55. DJ Schlieben, SM Korbet, EJ Lewis, R Kimura: Placental transmission of pathogenic antineutrophil

cytoplasmic antibodies. JASN 2003; (abst).

56. SW Kraft, MM Schwartz, SM Korbet, EJ Lewis: A new pathogenetic mechanism in lupus nephritis:

Lupus podocytopathy. JASN 2003; (abst).

57. SM Korbet, MM Schwartz, J Evans, EJ Lewis: Severe lupus nephritis: Racial differences in

presentation, response to treatment and outcome. JASN 2005; (abst).

58. NC Reddy, SM Korbet, JA Wozniak, EJ Lewis: Nursing home dialysis: Patient characteristics and

outcomes. JASN 2005; (abst) poster.

59. MM Schwartz, SM Korbet,RS Katz, EJ Lewis: Glomerular necrosis in diffuse lupus

glomerulonephritis. ASN 2006 (abst) poster.

60. YE Chen, SM Korbet, RS Katz, MM Schwartz, EJ Lewis: The value of a partial remission in severe

lupus nephritis. ASN 2006 (abst) poster.

61. RS Katz, MM Schwartz, SM Korbet, EJ Lewis: Necrotizing glomerulonephritis in diffuse lupus

glomerulonephritis. (abst) American College of Rheumatology 2006, accepted as a poster.

62. RS Katz, SM Korbet, MM Schwartz, EJ Lewis: The value of a partial remission in severe lupus

nephritis. (abst) American College of Rheumatology 2006, accepted as an oral presentation.

63. B Waldo, S Korbet, M Freimanis, E Lewis: The value of renal ultrasound in predicting

complications after percutaneous renal biopsy of native kidneys. ASN 2007 (abst) poster.

Page - 21

64. V Behara, W Whittier, S Korbet, M Schwartz, M Martens, E Lewis: Severe segmental lupus

nephritis: a pauci-immune glomerulonephritis. ASN 2007 (abst) poster.

65. MM Schwartz, SM Korbet, EJ Lewis: The prognosis and pathogenetic significance of severe focal

segmental lupus glomerulonephritis. ASN 2007 (abst).

66. SB Patel, SM Korbet, EJ Lewis: The prognosis of severe lupus nephritis based on the MDRD-GFR

at biopsy. ASN 2008 (abst) poster.

67. J Kopp, M Smith, G Nelson, R Johnson, B Freedman, D Bowden, T Olesyk, L McKenzie, H

Kajiyama, T Ahuja, J Berns, W Briggs, M Cho, R Dart, P Kimmel, S Korbet, D Michel, M Mokrzycki, J

Schelling, E Simon, H Trachtman, D Vlahov, C Winkler: Genome wide admixture mapping identifies

MYH9 as a Major Effect Gene for focal segmental glomerulosclerosis and hypertensive end-stage renal

disease. ASN 2008 (abst) Free communication [FC-254].

68. M Sika, M Koury, C Connelly, R Niecestro, T Greene, S Korbet, J Lewis: Evaluation of ferric

citrate as a phosphate binder in dialysis patients requiring high doses of phosphate binders. ASN 2009

(abst), poster.

69. TY Yau, SM Korbet, MM Schwartz, DJ Cimbaluk: Use of the Oxford classification of IgA

nephropathy top predict outcome: A retrospective analysis. ASN 2010 (abst), Poster.

70. SM Korbet, EJ Lewis: Complete remission in severe lupus nephritis: Assessing the rate of loss in

proteinuria. ASN 2011 (abst), Published.

71. A Lin, KS Keim, S Korbet, S Floramo-Korbet: Development of nutritional status assessment tool in

a hemodialysis population. NKF 2012 (abst).

72. SM Korbet, EJ Lewis: Severe Lupus Nephritis: The predictive value of a >50% reduction in

proteinuria at 6 months. ASN 2012 (abst), Poster.

73. SM Korbet, WL Whittier: Percutaneous Renal Biopsy of Native Kidneys: A single center experience

of over 1000 biopsies. ASN 2012 (abst), Poster.

74. KC Volpini, SM Korbet, WL Whittier: Timing of Complications of Percutaneous Native Kidney

Biopsy. ASN 2012 (abst), Poster.

75. S Chunduri, WL Whittier, SM Korbet: Percutaneous Renal Biopsy of Native Kidneys using Real

time Ultrasound: Adequacy and complications rates with 14 vs. 16 gauge automated needles. ASN 2014

(abst).

76. WL Whittier, K. Sayeed, SM Korbet: The effect of anemia on complication rate after Percutaneous

Renal Biopsy. ASN 2014 (abst).

77. SM Korbet, WL Whittier, EJ Lewis: Complete Remission Rate and Outcome in Severe Lupus

Nephritis: The impact of baseline serum creatinine. ASN 2015 (abst), Poster.

Page - 22

78. WL Whittier, S Saltzberg, SM Korbet: Comparison of Native and Transplant Percutaneous Renal

Biopsy: Safety and Diagnostic Yield. ASN 2015 (abst), Poster.

79. SM Korbet, WL Whittier: Risk of Percutaneous Renal Biopsy of Native Kidneys in the Evaluation of

Acute Renal Failure. ASN 2016 (abst). Poster

INVITED LECTURES:

1988 Grand Rounds, Grant Hospital, Chicago, Ill.

1988 National Kidney Foundation of Illinois, Annual Meeting, Oak Brook, IL

1988 Baxter, Peritoneal Dialysis Perspectives, Nappa Valley, Calif.

1988 14th Annual Meeting of Illinois Hospital Pharmacists, Rosemont, IL

1989 National Kidney Foundation of Illinois Patient Day, Champaign, IL

1989 Grand Rounds, University of Wisconsin Medical School, Madison, Wisconsin

1989 National Kidney Foundation of Wisconsin, 3rd Annual Professional Symposium, Madison, WI

1989 Illinois Council of Nephrology Social Workers, Chicago, IL

1989 Baxter, Advanced Peritoneal Dialysis Program, Deerfield, IL

1989 National Association of Nephrology Technologists, Technical Advances, Chicago, IL

1989 Baxter, Peritoneal Dialysis Initiatives Meeting, St. Petersburg, FL

1990 Baxter, Advanced Peritoneal Dialysis Program, Deerfield, IL (March)

1990 National Association of Nephrology Technologists, National Convention, Washington, D.C.

1990 Baxter, Advanced Peritoneal Dialysis Program, Deerfield, IL (June)

1990 Edward Hospital, Continuing Medical Education Program, Naperville, IL (June)

1990 Baxter, International Clinical Coordinator Meeting, Chicago, IL (July)

1990 Baxter, Current Approaches in Peritoneal Dialysis, Deerfield, IL (September)

1990 Baxter, Peritoneal Dialysis Initiatives Meeting, Palm Springs, Calif (October)

1990 Nephrology clinical conference, Bowman-Gray School of Medicine, Winston-Salem, NC (November)

1991 Baxter, Advanced Peritoneal Dialysis Program, Deerfield, IL (March)

1991 The Methodist Medical Center, Continuing Medical Education Conference, Peoria, IL (April)

1991 Nephrology Clinical Conference, Evanston Hospital, Evanston, IL (April)

1991 National Kidney Foundation of Illinois, 11th Annual Patient Education Day, Hickory Hills, IL (June)

1991 American Association of Kidney Patients Meeting, Chicago Chapter, Chicago, IL (June)

1991 Baxter, West Suburban Dialysis Center PD Perspectives, Schaumburg, IL (July)

1991 Baxter, International Clinical Coordinator Meeting, Chicago, IL (July)

1991 Cook County Graduate School of Medicine, Specialty Review in Internal Medicine, Chicago, IL (August)

1991 Baxter, Peritoneal Dialysis Initiatives Meeting, Hilton Head, SC (October)

1991 University of Louisville, Section of Nephrology-Clinical conference, Louisville, Kentucky (October)

1992 Baxter, Peritoneal Dialysis Perspectives, St. Moritz, Switzerland (January)

1992 Baxter, Advanced Peritoneal Dialysis Program, Deerfield, IL (April)

1992 National Kidney Foundation of Virginia, Annual Symposium, Richmond, Virginia (June)

1992 Cook County Graduate School of Medicine, Specialty Review in Internal Medicine, Chicago, IL (August)

1992 NKF 42nd Annual Meeting, Renal Pathology Society, (FSGS), Baltimore, (Nov)

1992 Am Soc of Nephrology 25th Annual Meeting, Clinical Science Symposium (CAPD), Baltimore, (Nov)

1992 Baxter Tokyo, Peritoneal Dialysis Perspectives, Maui, Hawaii (November)

1993 Visiting Professor, Vanderbilt Univ Medical Center, Renal Grand Rounds (FSGS), Nashville, TN (March)

1993 XIIth ISN Congress, State of the Art Lecture: Immunotactoid glomerulopathy, Jerusalem, (June)

1993 The National Center for Advanced Medical Education, Review in Internal Medicine, Chicago, (August)

1993 XXIInd Annual Conference of the EDTA/EDTNA, Options in Renal Therapy, Glasgow, (September)

1993 Baxter, Options in Renal Therapy, Scottsdale, AZ (October)

Page - 23

1993 Am Soc of Nephrology 26th Annual Meeting, Chaired session-Nephrotic Syndrome, Boston, (November)

1994 Grand Rounds, Illinois Masonic Hospital, Chicago, Il (January)

1994 Clinical Pathologic Conference, 14th Annual Conference on Peritoneal Dialysis, Orlando, FL, (January)

1994 Holy Cross Hospital Update in Medicine, Ft Lauderdale, Florida, (April)

1994 Nephrology Conference, Ospedale Di Mestre, Mestre, Italy (May)

1994 The National Center for Advanced Medical Education, Review in Internal Medicine, Chicago (July)

1994 The National Center for Advanced Medical Education, Review in Nephrology, Chicago, (September)

1994 ASN 27th Annual Meeting, Short Course-Complications of Peritoneal Dialysis, Orlando, FL (October)

1995 14th Annual Advanced Nephrology: Nephrology for the Consultant, San Diego, California (February)


1995 XIIIth International Congress of Nephrology, CME Course, FSGS, Madrid, (July)

1995 ASN 28th Annual Meeting, Contoversial issues in treating the nephrotic syndrome, San Diego (Nov)

1995 ASN 28th Annual Meeting, Short Course-Diagnostic approaches, San Diego, (Nov)

1996 NKF, 5th Annual Spring Meetings: PET: Avoiding the Pitfalls-Utilizing the Results, Anaheim, (April)

1996 11 Congresso Portugues De Nefrologia: Fibrillary Glomerulopathies, Setubal, Portugal(June)

1996 Renal Dis and Electrolyte Disorders [Schrier Course]: Treatment of Nephrotic Syndrome, Aspen (July)

1996 The National Center for Advanced Medical Education, Review in Internal Medicin, Chicago (July)

1996 The National Center for Advanced Medical Education, Review in Nephrology, Chicago (October)

1996 ASN 29th Annual Meeting, Changing Picture of FSGS, Treatment of FSGS, New Orleans (November)

1996 The National Ctr for Advanced Med Edu, Update on Treatment of Glomerular Disease, Chicago (Nov)

1996 Update in Internal Medicine Using the MKSAP 10 Progam: Nephrology, Chicago, IL, (November)

1997 XIVth International Congress of Nephrology, CME Course, Primary FSGS, Sydney, (May)


1997 Visiting Professor, Division of Nephrology, University of Western Ontario, London, Ontario (October)

1997 NKF, Annual Meetings: Peritoneal and Hemodialysis Adequacy: A DOQI Update, San Antonio (Novr)

1997 ASN 30th Annual Meeting, Renal Biopsy: Interpretation and Clinical Application, San Antonio (Nov)

1997 29th Course on Advances in Nephrology: Clinical Picture and Outcome of Primary FSGS, Milan (Dec)

1998 The 18th Annual CAPD Conf: Decreased Drain Volumes: Diagnosis and Management, Nashville (Feb)

1998 The 18th Annual CAPD Conference: Work-Up of Ultrafiltration Failure, Nashville (February)

1998 ASN 31st Annual Meeting, Renal Biopsy: Interpretation and Clinical Application, Philadelphia (October)

1999 Visiting Professor, Division of Nephrology, Cleveland Clinic Foundation, Cleveland OH (January)

1999 The XIXth Annual CAPD Conf: Scope and Diagnosis of Ultrafiltration Failure, Charlotte (March)

1999 The XIXth Annual CAPD Conf: Peritoneal Catheters: Advantages and Disadvantages, Charlotte (March)

1999 Visiting Professor, Division of Nephrology, University of Chicago, FSGS (March)

1999 Visiting Professor, Vanderbilt Univ Medical Ctr, Renal Grand Rounds (PD vs HD), Nashville, TN (May)

1999 Specialty Review Course in Medicine, Glomerular Diseases, Loyola University, Maywood, IL (May)

1999 3rd Seminar in Nephrology: Treatment of Primary FSGS and FSGS CPC, Thessaloniki, Greece (Sept)

1999 Stage nefrologico, Seminar on ESRD in the United States, Chicago (October)

2000 Nephrology Grand Rounds, Evanston Northwestern Healthcare, Evanston, IL (February)

2000 Specialty Review Course in Medicine, Glomerular Diseases, Loyola University, Maywood, IL (May)

2000 Nephrology Update, Dompe Biotec in nefrologia, Primary FSGS, Chicago (June)

2000 ASN 33rd Annual Meeting, Update on Glomerular Diseases Course, Toronto (October)

2000 ASN 33rd Annual Meeting, Minimal change disease and FSGS: Treatment, Toronto (October)

2000 ASN 33rd Annual Meeting, Dysproteinemia: Amyloid versus Fibrillary nephritis, Toronto (October)

2000 ASN 33rd Annual Meeting, Nephrology Quiz and Questionnaire, Toronto (October)

2001 Visiting Professor, The Toronto General/Western Hospitals, Toronto (January)

2001 Immunotherapy in Nephrology (2nd Int Congress), Treatment of FSGS, Sardinia, Italy (May)

2001 NephroAsia 2001, Nephrotic Syndrome- Classification and Therapy, Singapore (June)

2001 NephroAsia 2001, Therapeutic Controversies in Glomerulonephritis, Singapore (June)

Page - 24

2001 NephroAsia 2001, Diagnostic and Treatment Issues in Glomerulonephritis, Singapore (June)

2001 ASN 34th Annual Meeting, Update on Glomerular Diseases Course, San Francisco (October)

2001 ASN 34th Annual Meeting, Minimal change disease and FSGS: Treatment, San Francisco (October)

2001 ASN 34th Annual Meeting, Dysproteinemia: Amyloid vs Fibrillary nephritis, San Francisco (October)

2001 ASN 34th Annual Meeting, Nephrology Quiz and Questionnaire, San Francisco (October)

2001 Visiting Professor, Winthrop University Hospital-SUNY, New York (November)

2001 Visiting Professor, North Shore University Hospital, New York (November)

2002 Visiting Professor, Division of Nephrology, Cleveland Clinic Foundation, Cleveland OH (March)

2002 Nephrology Forum: Treatment of FSGS, Tufts-New England Medical Center, Boston MA (April)

2002 12th PanHellenic Congress of Nephrology: Treatment of Primary FSGS, Ioannina Greece (June)

2002 Harvard Medical School-Board Review in Nephrology: HIVAN, Boston (August)

2002 Harvard Medical School-Board Review in Nephrology: GN Cases for the Boards, Boston (August) 2002 Prevention in Renal Disease: Update on treatment trials in GN, Toronto (September)

2002 ASN 35th Annual Meeting, Update on Glomerular Diseases Course, Philadelphia (October)

2002 ASN 35th Annual Meeting, Minimal change disease and FSGS: Treatment, Philadelphia (October)

2002 ASN 35th Annual Meeting, Dysproteinemia: Amyloid vs Fibrillary nephritis, Philadelphia (October)

2002 ASN 35th Annual Meeting, Renal Biopsy, Philadelphia (October)

2002 ASN 35th Annual Meeting, Renal Biopsy: Interpretation and Clinical Application, Philadelphia (October)

2002 Visiting Professor, Division of Nephrology, University of Arizona, Tucson, AZ (November)

2003 NKF Annual Meeting, The Deposition Diseases, Dallas, TX (April)

2003 ASN 36th Annual Meeting, Update on Glomerular Diseases Course, San Diego (November)

2003 ASN 36th Annual Meeting, Puzzling Cases of CKD: An Update, San Diego (November)

2003 Visiting Professor, Vanderbilt Univ Medical Ctr, Renal Grand Rounds (HIVAN), Nashville, TN (Dec)

2004 Visiting Professor, Cedars-Sinai Medical Ctr, Renal Grand Rounds (FSGS), Los Angeles, CA (Jan)

2004 Neoral in nephrotic syndrome International workshop, Basel, Switzerland (Jan)

2004 Visiting Professor, Christ Hospital, Medical Grand Rounds, Oak Lawn, IL (Jan)

2004 ASN Regional Meeting, Update on Parenchymal Renal Disease, Chicago, IL (Feb)

2004 NKF Annual Meeting, Risk factors and treatment for FSGS, Chicago, IL (April)

2004 Visiting Professor, Indiana University, Indianapolis, IN (May)

2004 ASN 37th Annual Meeting, Update on Glomerular Diseases Course, St Louis (November)

2005 ASN Regional Meeting, Update on Parenchymal Renal Disease, Dallas, TX (Jan)

2005 ASN Regional Meeting, Update on Parenchymal Renal Disease, Chicago, IL (Feb)

2005 Visiting Professor, Mayo Clinic, Rochester MN (April)

2005 18th

Annual SIU Nephrology Symposium, Classification and Mgt of Lupus Nephritis, Springfield, IL (May)

2005 ASN 38th Annual Meeting, Update on Glomerular Diseases Course, Philadelphia (November)

2005 ASN 38th Annual Meeting, Immunotactoid glomerulopathy, Philadelphia (November)

2006 26th

Annual Dialysis Conference, Nursing home dialysis, San Francisco (February)

2006 ASN 39th Annual Meeting, Update on Glomerular Diseases Course, San Diego (November)

2006 ASN 38th Annual Meeting, Clinicopathologic Conference (Discussant), San Diego (November)

2007 NKF Annual Meeting, Moderator: Glomerulonephritis Workshop, Orlando, Fl (April)

2007 Visiting Professor, Ohio State University Medical Center, Columbus, OH (April)

2007 Grand Rounds (FSGS), Cook County Hospital, Chicago, IL (May)

2007 ASN Annual Meeting, Update on Glomerular Diseases Course, San Francisco (November)

2007 ASN Annual Meeting, Mycophenolate in Lupus and Non-glomerular renal disease, San Francisco (November)

2007 ASN Annual Meeting, Clinicopathologic Conference (Moderator), San Francisco (November)

2008 Grand Rounds- Internal Medicine, Rush University Medical Center (Hyponatremia), Chicago, IL (February)

2008 NKF Annual Meeting, Update on primary glomerular diseases: FSGS, Dallas, TX (April)

2008 ASN Annual Meeting, Update on Glomerular Diseases Course, Philadelphia (November)

2009 Grand Rounds- Internal Medicine, JFK Medical Center (Nephrotic syndrome), Boca Raton, FL (January)

Page - 25

2009 ASN Renal Weekend, Update on Parenchymal Renal Disease, Washington DC (Feb)

2009 Visiting Professor, Division of Nephrology, University of Western Ontario, London, Ontario (February)

2009 ASN Renal Weekend, Update on Parenchymal Renal Disease, Chicago, IL (March)

2009 XVI Congress Argentine Nephrology Society, Nodular glomerulosclerosis & FSGS, Mar del Plata, Argentina (Sept)

2009 ASN Annual Meeting, Update on Glomerular Diseases Course, San Diego, Calif (October)

2010 ASN Renal Weekend, Update on Parenchymal Renal Disease, Washington DC (Feb)

2010 ASN Renal Weekend, Update on Parenchymal Renal Disease, Chicago, IL (March)

2010 Grand Rounds (Contrast Nephropathy), Cook County Hospital, Chicago, IL (April)

2010 Visiting Professor, Univ. of Louisville, Grand Rounds & Nephrology conference, Louisville, Kentucky (May)

2010 ASN Board Review Course, Primary Glomerulonephritides, San Francisco, Calif (August)

2010 ASN Annual Meeting, Update on Glomerular Diseases Course, Denver, CO (November)


2011 ASN Annual Meeting, Update on Glomerular Diseases Course, Philadelphia, PA (November)


2012 Visiting Professor, Henry Ford Medical Center, Grand Rounds & Nephrology conference, Detroit, MI (Sept)

2012 Visiting Professor, Advocate Christ Medical Center, Medical Grand Rounds, Oak Lawn, IL (Dec)

2013 ASN Board Review Course, Primary Glomerulonephritides, Chicago, IL (August)

2013 Visiting Professor, Loyola University Medical Center, Medical Grand Rounds, Maywood, IL (August)

2013 ASN Annual Meeting Moderator: Treating “Refractory” Nephrotic Syndrome, Atlanta (November)

2014 Visiting Professor, Wake Forest Univ. School of Medicine, Nephrology conference, Winston-Salem, NC (January)

2014 ASN Board Review Course, Primary Glomerulonephritides, Chicago, IL (August)

2015 ASN Board Review Course, Primary Glomerulonephritides, Chicago, IL (July)

2016 NIDDK: Kidney Precision Medicine Workshop, Renal biopsy in AKI and Workshops, Bethesda, MD (May)

2016 Nephcure Regional Nephrotic Syndrome Symposium, Primary GN, Chicago, IL (June)

2016 New York Society of Nephrology Lecture Series, Severe Lupus Nephritis: The Rush Experience, NY (December)

2016 Stroger Hospital Grand Rounds Lupus Nephritis: The Rush Experience, Chicago (December)

stephen michael korbet, md, facp - rush university medical... · 1979-1980 internship-...

Documents